Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell or T-Cell Lymphoma.
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2015
At a glance
- Drugs Clofarabine (Primary)
- Indications B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 28 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Jun 2009 Planned end date changed from Oct 2009 to Oct 2010 as reported by ClinicalTrials.gov.
- 14 Nov 2007 Expected recruitment has been reduced to 21 from 40 participants.